(RTTNews) - Sanofi - Aventis Groupe said results from the LUNA 3 phase 3 study showed that rilzabrutinib 400 mg twice daily orally achieved the primary endpoint of durable platelet response in ...
Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential of ...
Pivotal data from the first phase 3 study of a BTKi in immune thrombocytopenia (ITP) underscore the potential of rilzabrutinib to provide a clinically meaningful benefit to patients living with ITP ...
Corcept Therapeutics (NASDAQ:CORT) is off 3% in Monday morning trading after reporting what it called positive results from a phase 3 trial of a Cushing's syndrome candidate but didn't provide ...
The reigning champions are now four points behind Rangers and six points behind Celtic with five games left to play. Formation 4-2-3-1 Formation 4-3-3 ...
Lok Sabha polls 2024 LIVE: A voter turnout of 68.35 per cent was recorded till 3 pm in Tripura where polling underway in the first phase of Lok Sabha polls today, officials said. Sporadic incidents of ...
Lok Sabha Elections 2024 Phase 1 Highlights: 41.51% voter turnout in 12 seats in Rajasthan till 3 pm
The first phase of voting for the 2024 Lok Sabha election ... Tripura (1), Uttar Pradesh (8), Uttarakhand (5), West Bengal (3), Andaman and Nicobar (1), J&K (1), Lakshadweep (1) and Puducherry ...
In the first phase, there are 35.67 lakh first time voters, besides 3.51 crore young voters in the age group of 20-29 years. Polling is being held for all seats of Tamil Nadu (39), Uttarakhand (five), ...
SIBU: A lorry driver died in a hydraulic oil drum explosion at a scrap metal yard on Jalan Tunku Abdul Rahman here on Thursday (April 18). Sibu District police chief ACP Zulkipli Suhaili stated ...
The third phase of voting for Lok Sabha election 2024 will be held on May 7. This phase will encompass 94 constituencies spread across 12 states. The Election Commission initiated this process ...
(RTTNews) - AbbVie Inc. (ABBV) Thursday announced positive results from SELECT-GCA Phase 3 of Upadacitinib 15 mg, once daily in combination with a 26-week steroid taper regimen in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results